We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+17.36%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.98B
AUM Growth
+$266M
Cap. Flow
+$123M
Cap. Flow %
6.23%
Top 10 Hldgs %
54.68%
Holding
148
New
19
Increased
38
Reduced
28
Closed
8

Top Buys

Rank Stock Value
1
FULC icon
Fulcrum Therapeutics
FULC
+$35.4M
2
TITN icon
Titan Machinery
TITN
+$24.4M
3
BKSY icon
BlackSky Technology
BKSY
+$19.4M
4
CRMT icon
America's Car Mart
CRMT
+$13.5M
5
PWSC
PowerSchool Holdings, Inc.
PWSC
+$13.2M

Top Sells

Rank Stock Value
1
CASH icon
Pathward Financial
CASH
+$17.8M
2
IMAX icon
IMAX
IMAX
+$10.2M
3
BVS icon
Bioventus
BVS
+$8.54M
4
ESTA icon
Establishment Labs
ESTA
+$6.68M
5
RDNW
RideNow Group
RDNW
+$5.58M

Sector Composition

Rank Sector Weight
1 Healthcare 41.22%
2 Consumer Discretionary 6.49%
3 Communication Services 3.21%
4 Financials 3.01%
5 Industrials 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$79.8B
$409M 20.67%
1,850,000
+500,000
+37% +$107M
SLNO
2
DELISTED
Soleno Therapeutics
SLNO
$165M 8.35%
3,270,448
+188,341
+6% +$9.02M
ESTA icon
3
Establishment Labs
ESTA
$2.72B
$102M 5.16%
2,359,141
-153,709
-6% -$6.68M
LLY icon
4
PUT
Eli Lilly
LLY
$1.02T
$79.7M 4.03%
90,000
-70,000
-44% -$62.9M
XBI icon
5
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$79M 4%
800,000
-400,000
-33% -$39.3M
LOPE icon
6
PUT
Grand Canyon Education
LOPE
$3.79B
$56.7M 2.87%
400,000
– –
BVS icon
7
Bioventus
BVS
$892M
$52M 2.63%
4,350,870
-987,444
-18% -$8.54M
PTON icon
8
Peloton Interactive
PTON
$2.77B
$48.5M 2.45%
10,353,631
-581,700
-5% -$2.29M
EOLS icon
9
Evolus
EOLS
$385M
$45.8M 2.32%
2,824,849
-86,000
-3% -$1.2M
SYK icon
10
PUT
Stryker
SYK
$125B
$43.4M 2.19%
+120,000
New +$41.4M
PTON icon
11
CALL
Peloton Interactive
PTON
$2.77B
$38.8M 1.96%
8,289,700
+302,700
+4% +$1.19M
TBBK icon
12
The Bancorp
TBBK
$2.79B
$31.5M 1.59%
588,160
+250,314
+74% +$12.1M
IMAX icon
13
CALL
IMAX
IMAX
$2.62B
$30.8M 1.56%
1,500,000
+500,000
+50% +$9.84M
HGV icon
14
Hilton Grand Vacations
HGV
$3.59B
$27.1M 1.37%
746,829
+77,958
+12% +$3.02M
IMAX icon
15
IMAX
IMAX
$2.62B
$26.2M 1.33%
1,278,774
-519,486
-29% -$10.2M
CRMT icon
16
America's Car Mart
CRMT
$26.6M
$22.8M 1.16%
544,686
+232,558
+75% +$13.5M
TITN icon
17
Titan Machinery
TITN
$396M
$22.6M 1.15%
+1,625,276
New +$24.4M
AMRX icon
18
Amneal Pharmaceuticals
AMRX
$5.85B
$22.2M 1.12%
2,669,943
– –
KROS icon
19
Keros Therapeutics
KROS
$199M
$22.2M 1.12%
381,659
+2,852
+0.8% +$141K
SVRA icon
20
Savara
SVRA
$1.12B
$22M 1.11%
5,180,951
– –
ABEO icon
21
Abeona Therapeutics
ABEO
$366M
$21.7M 1.1%
3,432,637
-37,400
-1% -$195K
ZVRA icon
22
Zevra Therapeutics
ZVRA
$562M
$20.3M 1.03%
2,924,021
+504,586
+21% +$3.42M
TRML
23
DELISTED
Tourmaline Bio
TRML
$18M 0.91%
700,907
– –
CASH icon
24
Pathward Financial
CASH
$1.86B
$17.4M 0.88%
264,203
-277,230
-51% -$17.8M
FULC icon
25
Fulcrum Therapeutics
FULC
$273M
$17.1M 0.86%
+4,777,912
New +$35.4M
1
2 3 4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return

Nantahala Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Nantahala Capital Management held 148 positions worth $1.98B, up 16% from $1.71B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Nantahala Capital Management deployed $123M of net new capital in Q3 2024, opening 19 new positions and adding to 38 existing holdings. Its largest new stake was Fulcrum Therapeutics: 4,777,912 shares worth $17.1M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Pathward Financial, an estimated $17.8M trimmed.

  • Nantahala Capital Management's largest Q3 2024 buy was Fulcrum Therapeutics: 4,777,912 shares worth $17.1M.
  • Nantahala Capital Management added most to America's Car Mart in Q3 2024, an estimated $13.5M increase.
  • Nantahala Capital Management's biggest Q3 2024 reduction was Pathward Financial, cutting an estimated $17.8M.
  • Nantahala Capital Management fully exited Avadel Pharmaceuticals in Q3 2024, selling an estimated $4.92M.
  • Nantahala Capital Management's ten largest holdings make up 55% of its $1.98B portfolio in Q3 2024.
  • Nantahala Capital Management opened 19 new positions and closed 8 in Q3 2024.
  • Nantahala Capital Management's portfolio value rose 16% quarter-over-quarter to $1.98B.

Based on Nantahala Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.